September 08, 2008
Article
A trek to the finish line.
ICI Response May Predict Relapse-Free Survival in Liver Cancer
Taking Time to ‘Smell the Roses’
Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma
A Phase 3 Trial of Amezalpat in Advanced Liver Cancer Receives Study May Proceed Letter